Recombinant Biotechnology and Immunotherapy Centre
Public support
Provider
Ministry of Education, Youth and Sports
Programme
—
Call for proposals
—
Main participants
Univerzita Palackého v Olomouci / Lékařská fakulta
Contest type
OP - EU Operational Programme
Contract ID
16_025/0007397_01
Alternative language
Project name in Czech
Centrum pro Rekombinantní biotechnologie a imunoterapeutika
Annotation in Czech
"Projekt je zaměřen na vývoj rekombinantních vysokoafinitních ligandů, rekombinantních preteinových a DNA vakcín s korpuskulárními nosiči a molekulárními adjuvans, což představuje nový biotechnologický trend ve vývoji rekombinantních vakcín, vysoce selektivních imunoterapeutik, diagnostik a teranostik. Úspěšné zvládnutí multioborového výzkumu je postaveno na spolupráci čtyř renomovaných týmů, které mají vysokou kvalitu personálního zajištění a infrastruktury. Tyto týmy pojí dlouhodobá spolupráce, která je doložena společnými projekty, publikacemi a patenty."
Scientific branches
R&D category
AP - Applied research
OECD FORD - main branch
30401 - Health-related biotechnology
OECD FORD - secondary branch
30401 - Health-related biotechnology
OECD FORD - another secondary branch
10608 - Biochemistry and molecular biology
CEP - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
CE - Biochemistry<br>EB - Genetics and molecular biology<br>EI - Biotechnology and bionics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
In accordance with the project application there was purchased all the equipment necessary to ensure the smooth implementation of the CEREBIT project both on the part of the recipient and the individual partners. Project research was focused on the testing of vaccine substances and the development of proteins for the treatment of immunologically mediated diseases. In the course of the project there was established or developed a cooperation with research subjects dedicated to biotechnology and the issue of autoimmune diseases. Cooperation was also established with commercial partners, both domestic and from abroad (Great Britain, Belgium and Germany). Several international project applications were prepared during the implementation of the CEREBIT project. The results of the project became the basis for establishing cooperation with a group of private entities, which resulted in the preparation of a joint grant application.
Solution timeline
Realization period - beginning
Jan 1, 2018
Realization period - end
Feb 28, 2023
Project status
U - Finished project
Latest support payment
Sep 6, 2020
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP24-MSM-EF-U
Data delivery date
Jul 1, 2024
Finance
Total approved costs
77,301 thou. CZK
Public financial support
77,301 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
3,691 thou. CZK